1-{3-[4-(1-hydroxy-1-propylbutyl)phenoxy]propyl}piperidine

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 1-{3-[4-(1-hydroxy-1-propylbutyl)phenoxy]propyl}piperidine
• 英文别名: 1-{3-[4-(1-Hydroxy-1-propylbutyl)-phenoxy]propyl}piperidine；4-[4-(3-piperidin-1-ylpropoxy)phenyl]heptan-4-ol
• 化学式: C₂₁H₃₅NO₂
• 分子量: 333.514
• InChiKey: PETWWIOECLOXGN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.6
• 重原子数：
  24
• 可旋转键数：
  10
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.71
• 拓扑面积：
  32.7
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  1-{3-[4-(1-hydroxy-1-propylbutyl)phenoxy]propyl}piperidine 、 草酸 以 乙醇 为溶剂， 生成 1-{3-[4-(1-hydroxy-1-propylbutyl)phenoxy]propyl}piperidine oxalate
  参考文献：
  名称：

  Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3-receptor ligands

  摘要：

  本专利申请涉及公式（I）的化合物，其中R1和R2与它们所连接的氮原子一起形成一个单环或双环饱和氮含环；它们的制备以及它们作为H3受体配体用于治疗例如阿尔茨海默病等中枢神经系统疾病。

  公开号：

  EP1717234A1
• 作为产物：
  描述：

  1-溴-4-(3-氯丙氧基)苯 在 potassium carbonate 、 magnesium 、 potassium iodide 作用下， 以 四氢呋喃 、 N,N-二甲基甲酰胺 为溶剂， 反应 16.5h， 生成 1-{3-[4-(1-hydroxy-1-propylbutyl)phenoxy]propyl}piperidine
  参考文献：
  名称：

  Novel and highly potent histamine H3 receptor ligands. Part 3: An alcohol function to improve the pharmacokinetic profile

  摘要：

  Synthesis and biological evaluation of potent histamine H-3 receptor antagonists incorporating a hydroxyl function are described. Compounds in this series exhibited nanomolar binding affinities for human receptor, illustrating a new possible component for the H-3 pharmacophore. As demonstrated with compound BP1.4160 (cyclohexanol 19), the introduction of an alcohol function counter-intuitively allowed to reach high in vivo efficiency and favorable pharmacokinetic profile with reduced half-life. (C) 2013 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2013.02.118

文献信息

• COMBINATION OF MODAFINIL AND AN ANTAGONIST OR INVERSE AGONIST OF THE H3 RECEPTOR
  申请人：Schwartz Jean-Charles

  公开号：US20090312367A1

  公开（公告）日：2009-12-17

  The invention relates to a combination of modafinil and at least one histamine H3 receptor antagonist or inverse agonist, which can be used in particular for the treatment of narcolepsy-cataplexy and more generally for disorders of sleep, wakefulness and vigilance.

  本发明涉及调节药物莫达非尼和至少一种组胺H3受体拮抗剂或反向激动剂的组合，特别适用于治疗嗜睡症-猝倒症，更广泛地适用于睡眠、清醒和警觉障碍的治疗。
• NOVEL HISTAMINE H3-RECEPTOR LIGANDS AND THEIR THERAPEUTIC APPLICATIONS
  申请人：Bertrand Isabelle

  公开号：US20090111808A1

  公开（公告）日：2009-04-30

  The present patent application concerns compounds of formula (I) with R1 and R2 taken together with the nitrogen atom to which they are attached, form a mono or bicyclic saturated nitrogen-containing ring; their preparation and their use as a H3 receptor ligand for treating e.g. CNS disorders like Alzheimer's disease.

  本专利申请涉及式(I)的化合物，其中R1和R2与它们所连接的氮原子结合形成单环或双环饱和含氮环; 它们的制备及其用作H3受体配体，用于治疗例如阿尔茨海默病等中枢神经系统疾病。
• Histamine H3-receptor ligands and their therapeutic applications
  申请人：Bioprojet

  公开号：US08076329B2

  公开（公告）日：2011-12-13

  The present patent application concerns compounds of formula (I) with R1 and R2 taken together with the nitrogen atom to which they are attached, form a mono or bicyclic saturated nitrogen-containing ring; their preparation and their use as a H3 receptor ligand for treating e.g. CNS disorders like Alzheimer's disease.

  本专利申请涉及公式（I）化合物，其中R1和R2与它们附着的氮原子一起形成单环或双环饱和含氮环；它们的制备以及它们作为H3受体配体用于治疗例如阿尔茨海默病等中枢神经系统疾病。
• DERIVATIVES OF 1-N-AZACYCLOALKYL-3-PHENOXYPROPANE USEFUL FOR THE PREPARATION OF PSYCHOTROPIC MEDICAMENTS
  申请人：BIOPROJET

  公开号：EP1874746B1

  公开（公告）日：2015-11-18
• ASSOCIATION DE MODAFINIL ET D'UN ANTAGONISTE OU AGONISTE INVERSE DU RECEPTEUR H3
  申请人：BIOPROJET

  公开号：EP2043624A2

  公开（公告）日：2009-04-08